Koten Acupuncture Gold Coast – Acupuncture
Acupuncture treats Migraine
If you do not suffer from Migraine, you can class yourself extremely lucky. Migraine is a seriously debilitating phenomenon, affecting the lives of many people around the world. Migraine suffers experience so much discomfort, it leaves them physically sick and in a state total exhaustion.
The causative factors for Migraine are unknown and remain to be hypothesized. At the front line of treatment is an assortment of powerful pharmaceutical medications that result in many unwanted and adverse side effects. From an East Asian Medical perspective, Migraine suffers generally present as a number subtypes within the diagnostic process and treatment of Migraine with Acupuncture is almost always effective.
In recent years there has been numerous studies supporting the efficacy of Acupuncture for the treatment of Migraine. The study below is not only significant because once again it concludes Acupunctures effectiveness, it compares the outcomes of Acupuncture for the treatment of Migraine against one of the leading Migraine medications Rizatriptan and a number of other treatment options
The study concluded that Acupuncture was the only treatment able to provide a steady outcome improvement in comparison to the use of only Rizatriptan, while RMA (ritualized mock acupuncture plus Rizatriptan) showed a transient placebo effect at T1.
Acupuncture is a drug free treatment option and At koten Acupuncture Gold Coast we treat your Migraine with traditional Acupuncture, and have a great network of allied health professionals to help keep you pain free and and in good health.
Traditional acupuncture in migraine: a controlled, randomized study. University of Padua – Department of Medico-Surgical Specialties – Sect. Dentistry, Padua, Italy.
To check the effectiveness of a true acupuncture treatment according to traditional Chinese medicine (TCM) in migraine without aura, comparing it to a standard mock acupuncture protocol, an accurate mock acupuncture healing ritual, and untreated controls.
DESIGN AND METHODS:
A prospective, randomized, controlled study was performed in 160 patients suffering from migraine without aura, assessed according to the ICD-10 classification. The patients were divided into the following 4 groups:
(1) Group TA (Acupuncture) treated with true acupuncture (according to TCM) plus Rizatriptan;
(2) Group RMA, treated with ritualized mock acupuncture plus Rizatriptan;
(3) Group SMA, treated with standard mock acupuncture plus Rizatriptan;
(4) Group R, without prophylactic treatment with relief therapy only (Rizatriptan).
Participants The MIDAS Questionnaire was administered before treatment (T0), at 3 (T1) and 6 months (T2) from the beginning of treatment, and the MIDAS Index (MI) was calculated. Rizatriptan intake was also checked in all groups of patients at T0, T1, and T2. Group TA and RMA were evaluated according to TCM as well; then, the former was submitted to true acupuncture and the latter to mock acupuncture treatment resembling the same as TA. The statistical analysis was conducted with factorial ANOVA and multiple tests with a Bonferroni adjustment.
A total of 127 patients completed the study (33 dropouts): 32 belonged to group TA, 30 to group RMA, 31 to group SMA, and 34 to group R. Before treatment the MI (T(0)) was moderate to severe with no significant intergroup differences. All groups underwent a decrease of MI at T(1) and T(2), with a significant group difference at both T(1) and T(2) compared to T(0) (P < .0001).
Only TA (Acupuncture) provided a significant improvement at both T(1) and T(2) compared to Rizatriptan (P < .0001). RMA underwent a transient improvement of MI at T(1). The Rizatriptan intake paralleled the MI in all groups.
Acupuncture was the only treatment able to provide a steady outcome improvement in comparison to the use of only Rizatriptan, while RMA showed a transient placebo effect at T1.